Page 18 - Multiple Sclerosis Ms News Today

Changes in specific types of glycerophospholipids may contribute to reduced memory T cell subsets that are observed in people with multiple sclerosis on intermittent calorie restriction.

Epstein-Barr virus is the likely cause of multiple sclerosis, new research confirms. Investigators found the risk of MS increased 32-fold following EBV infection.

Whereas previous research suggests sunlight can be protective against MS development, a new study shows even half an hour of daily sun exposure risk cuts MS risk in half in children and young adults.

Although rituximab was consistently linked to better relapse outcomes vs natalizumab in new research, outcomes did not differ between dimethyl fumarate and fingolimod.

Although some repletion of B cells occurs with the B-cell depleting MS drug ocrelizumab, the effect does not appear to be associated with symptom worsening or a wearing off effect.

A 30-minute, automated, iPad-based NIH Toolbox Cognitive Battery may offer some key advantages over gold standard tools, with automated scoring that accounts for race/ethnicity.

People with MS and comorbid psoriasis may benefit from a careful consideration of disease-modifying therapy, specifically when B cell-depleting therapies are considered, said coauthor Ahmed Obeidat, MD.

A new consensus guideline, created collaboratively between three international organizations, has been designed to boost much-needed protocol adherence during routine clinical use of MRI.

Despite sweeping regulatory changes, usage of cannabis by patients with multiple sclerosis remains relatively steady, especially for treating spasticity, new research shows.

Paleolithic elimination and low-saturated fat diets are associated with improvements in fatigue, cognitive dysfunction, and quality of life in patients with multiple sclerosis, new research suggests.